Clinical research has evaluated doses up to 12 mg per week, depending on individual tolerance and treatment goals
Barkats M, Millecamps S, Abrioux P, Geoffroy MC, Mallet J
In a Phase 1 randomized, double-blind, placebo-controlled trial involving obese adults (NCT04478708), AMG 133 exhibited good safety and tolerability profiles and demonstrated significant dose-dependent weight loss effects
- Thnh phn : nc, glycerin, tinh cht vng 24k, vitamin B3, dng cht L-Glutathione, Ginkgo biloba, mm go
Patients who continue to experience discomfort beyond this window should discuss their symptoms with their prescribing provider to rule out other metabolic factors or medication interactions